| Chronic Kidney Disease and Diabetes | Lifetime | 57 | US 29 | 99.54 |
| Dialysis and Renal Disease Management | Lifetime | 86 | US 44 | 99.48 |
| Renal and Vascular Pathologies | Lifetime | 119 | US 74 | 99.02 |
| Potassium and Related Disorders | Lifetime | 40 | US 27 | 98.99 |
| Renal Diseases and Glomerulopathies | Lifetime | 235 | US 102 | 98.68 |
| Acute Kidney Injury Research | Lifetime | 180 | US 82 | 97.91 |
| Blood Pressure and Hypertension Studies | Lifetime | 612 | US 252 | 98.28 |
| Diabetes Treatment and Management | Lifetime | 590 | US 219 | 97.90 |
| Folate and B Vitamins Research | Lifetime | 786 | US 374 | 95.16 |
| Parathyroid Disorders and Treatments | Lifetime | 926 | US 366 | 95.21 |
| Electrolyte and hormonal disorders | Lifetime | 839 | US 394 | 94.02 |
| Organ Donation and Transplantation | Lifetime | 923 | US 441 | 94.44 |
| Sodium Intake and Health | Lifetime | 602 | US 256 | 91.78 |
| Magnesium in Health and Disease | Lifetime | 984 | US 354 | 81.37 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 5 | US 2 | 99.75 |
| Dialysis and Renal Disease Management | 2021-2025 | 18 | US 6 | 99.34 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 54 | US 21 | 98.82 |
| Diabetes Treatment and Management | 2021-2025 | 107 | US 50 | 98.73 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 157 | US 48 | 96.70 |
| Genetic Associations and Epidemiology | 2021-2025 | 325 | US 152 | 93.78 |
| Potassium and Related Disorders | 2021-2025 | 51 | US 26 | 95.70 |
| Electrolyte and hormonal disorders | 2021-2025 | 76 | US 28 | 92.33 |
| Acute Kidney Injury Research | 2021-2025 | 238 | US 76 | 91.00 |
| Diabetes Management and Research | 2021-2025 | 792 | US 293 | 91.52 |
| Folate and B Vitamins Research | 2021-2025 | 401 | US 87 | 79.78 |
| Hormonal Regulation and Hypertension | 2021-2025 | 836 | US 176 | 80.97 |
| GDF15 and Related Biomarkers | 2021-2025 | 291 | US 84 | 68.82 |
| Medication Adherence and Compliance | 2021-2025 | 846 | US 282 | 70.47 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 449 | US 120 | 68.57 |
| Pharmacology and Obesity Treatment | 2021-2025 | 812 | US 312 | 62.53 |
| Apelin-related biomedical research | 2021-2025 | 337 | US 54 | 59.27 |
| Magnesium in Health and Disease | 2021-2025 | 750 | US 153 | 34.25 |
